D. KOCAMAZ Et Al. , "Cushing syndrome and subclinical cushing syndrome with melanocortin 2 receptor mutations and clinical significances," 15th Scientific Symposium of the European Network for the Study of Adrenal Tumors , Birmingham, United Kingdom, pp.1, 2016
KOCAMAZ, D. Et Al. 2016. Cushing syndrome and subclinical cushing syndrome with melanocortin 2 receptor mutations and clinical significances. 15th Scientific Symposium of the European Network for the Study of Adrenal Tumors , (Birmingham, United Kingdom), 1.
KOCAMAZ, D., Akkus, G., & Menziletoğlu Yıldız, Ş., (2016). Cushing syndrome and subclinical cushing syndrome with melanocortin 2 receptor mutations and clinical significances . 15th Scientific Symposium of the European Network for the Study of Adrenal Tumors (pp.1). Birmingham, United Kingdom
KOCAMAZ, DERYA, GAMZE AKKUŞ, And Şule Menziletoğlu Yıldız. "Cushing syndrome and subclinical cushing syndrome with melanocortin 2 receptor mutations and clinical significances," 15th Scientific Symposium of the European Network for the Study of Adrenal Tumors, Birmingham, United Kingdom, 2016
KOCAMAZ, DERYA Et Al. "Cushing syndrome and subclinical cushing syndrome with melanocortin 2 receptor mutations and clinical significances." 15th Scientific Symposium of the European Network for the Study of Adrenal Tumors , Birmingham, United Kingdom, pp.1, 2016
KOCAMAZ, D. Akkus, G. And Menziletoğlu Yıldız, Ş. (2016) . "Cushing syndrome and subclinical cushing syndrome with melanocortin 2 receptor mutations and clinical significances." 15th Scientific Symposium of the European Network for the Study of Adrenal Tumors , Birmingham, United Kingdom, p.1.
@conferencepaper{conferencepaper, author={DERYA KOCAMAZ Et Al. }, title={Cushing syndrome and subclinical cushing syndrome with melanocortin 2 receptor mutations and clinical significances}, congress name={15th Scientific Symposium of the European Network for the Study of Adrenal Tumors}, city={Birmingham}, country={United Kingdom}, year={2016}, pages={1} }